{"vid":"V123","name":"q3p8c3","file_id":"F1","var_dcml":"0","var_intrvl":"discrete","var_width":"18","labl":"(iii) Duration of use","var_respunit":"Patients with type 2 diabetes being interviewed.","var_qstn_preqtxt":"Medications \nHas this changed in [COVID] period = the time you were most affected [if applicable]","var_qstn_qstnlit":"Think about the 3 months after [COVID]. Please indicate:\nFikiria kuhusu miezi 3 baada ya [COVID], kisha ueleze;\n(c) Duration (e.g. used for only one month;  for three months)\nMuda (k.m. kutumika kwa mwezi mmoja tu; kwa miezi mitatu)","var_qstn_postqtxt":"N\/A","var_qstn_ivulnstr":"N\/A","var_val_range":[{"units":"REAL","min":"1","max":"96"}],"var_universe":"Patients with type 2 diabetes","universe_clusion":"I","var_sumstat":[{"value":"485","type":"vald"},{"value":"15","type":"invd"}],"var_txt":"The question was asked to patients with type 2 diabetes to indicate the duration they used insulin during the three months of COVID-19 pandemic, specifically between March and June 2020.","var_catgry":[{"value":"1","labl":"(a) one month only","stats":"234","type":"freq"},{"value":"2","labl":"(b) two months","stats":"12","type":"freq"},{"value":"3","labl":"(c) three months","stats":"154","type":"freq"},{"value":"96","labl":"(96) Other specify","stats":"85","type":"freq"},{"value":"Sysmiss","labl":null,"stats":"15","type":"freq"}],"var_format":"numeric","var_format_schema":"other","var_notes":"\"(iii) Duration of use\"","fid":"F1","sid":"175","survey_idno":"DDI-KEN-APHRC-GEGO-2021-v1.0"}